Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors.

about

Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors.

Item

http://www.wikidata.org/entity/Q52099170

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Retrospective Analysis of Mole ...... n of 381 Primary Brain Tumors.

@en

Retrospective Analysis of Mole ...... n of 381 Primary Brain Tumors.

@nl

type

Item

label

Retrospective Analysis of Mole ...... n of 381 Primary Brain Tumors.

@en

Retrospective Analysis of Mole ...... n of 381 Primary Brain Tumors.

@nl

prefLabel

Retrospective Analysis of Mole ...... n of 381 Primary Brain Tumors.

@en

Retrospective Analysis of Mole ...... n of 381 Primary Brain Tumors.

@nl

P1476

Retrospective Analysis of Mole ...... n of 381 Primary Brain Tumors.

@en

P2093

Erik P Sulman

http://www.w3.org/2001/XMLSchema#string

Gregory N Fuller

http://www.w3.org/2001/XMLSchema#string

Keyur P Patel

http://www.w3.org/2001/XMLSchema#string

Leomar Y Ballester

http://www.w3.org/2001/XMLSchema#string

Mark J Routbort

http://www.w3.org/2001/XMLSchema#string

Rajyalakshmi Luthra

http://www.w3.org/2001/XMLSchema#string

Suzanne Z Powell

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

IDH1 and IDH2 mutations in gliomas

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The 2007 WHO classification of tumours of the central nervous system

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

The somatic genomic landscape of glioblastoma

Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas

Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.

Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.

P304

179-188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNEN/NLW119

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28395087

http://www.w3.org/2001/XMLSchema#string